Infexion, a division of Proxima Concepts is developing treatments for infectious diseases such as influenza, malaria, HIV, Hepatitis and several others. The company has exclusive licenses for proprietary drug discovery and drug delivery technologies such as Axess (for oral delivery of peptides and proteins), Vaxcine (Vaccine carriers), Mozaic (a system to construct receptors capable of binding to cell-surface ligands) and Lexicon (for modular design of peptide therapeutics). The company claims that its Vaxcine formulations for HIV and HSV infections have shown positive results in mice models.